FLUICELL ABFLUICELL ABFLUICELL AB

FLUICELL AB

No trades
See on Supercharts

FLUI fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Fluicell AB engages in the provision of fluid platforms for multi-functional pipettes for cell-based pharmacology research. Its products include Biopen Prime and Flex, Dynaflow Resolve, and Biopixlas. The company was founded by Aldo Jesorka, Alar Ainla, and Gavin David Michael Jeffries on January 2, 2012 and is headquartered in Molndal, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

FLUI does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company